CSIMarket
 
Aclaris Therapeutics Inc   (NASDAQ: ACRS)
 

Aclaris Therapeutics Inc's Suppliers Performance

ACRS's Supply Chain




 
ACRS Costs vs Sales of Suppliers Growth Aclaris Therapeutics Inc's cost of sales deteriorated by -57.67 % year on year, relative to one quarter ago cost of sales fell by -44.81 % in Q2.

• More on ACRS Suppliers



Aclaris Therapeutics Inc's cost of sales deteriorated by -57.67 % year on year, compare to one quarter ago cost of sales fell by -44.81 % in Q2.

• More on ACRS Suppliers




Aclaris Therapeutics Inc's Comment on Supply Chain









ACRS's vs. Suppliers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Aclaris Therapeutics Inc 738.66 8.22 -75.74 73
SUBTOTAL 0.00 0.00 0.00 -


Sources: Aclaris Therapeutics Inc 's official press releases and regulatory filings; CSIMarket.com's supply-chain research; and the financial filings and press releases of other companies cited in this report.
Updated on:
For your research, we’ve provided nine additional tables on Aclaris Therapeutics Inc ’s suppliers.
You can find them in the navigation menu under Suppliers.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.